LEP and endometrial cancer: Analysis of changes in the level of leptin in endometrial cancer cells exposed to cisplatin at the protein level showed that the statistically significant differences were visible for cells treated with 2.5 μM of cisplatin after only 48 h in comparison to the control (p = 0.0031).